-
EP3043773
European procedure
Extract from the Register of European Patents
EP About this file: EP3043773
| EP3043773 - STABLE FIXED DOSE PHARMACEUTICAL COMPOSITION COMPRISING MOMETASONE AND OLOPATADINE FOR NASAL ADMINISTRATION [Right-click to bookmark this link] | |||
| Former [2016/29] | STABLE FIXED DOSE PHARMACEUTICAL COMPOSITION COMPRISING MOMETASONE AND OLOPATADINE | ||
| [2020/49] | Status | The patent has been granted Status updated on 28.05.2021 Database last updated on 12.07.2024 | |
| Former | Grant of patent is intended Status updated on 08.12.2020 | ||
| Former | Examination is in progress Status updated on 16.03.2018 | Most recent event Tooltip | 08.06.2024 | New entry: Date of receipt of statement of grounds of an appeal | Applicant(s) | For all designated states Glenmark Specialty S.A. Avenue Léopold-Robert 37 2300 La Chaux-de-Fonds / CH | [2016/29] | Inventor(s) | 01 /
DHUPPAD, Ulhas Bunglow No. B-3 Coral Apt. Resi 1 -Phase Shahu Nagar, Motwani Factory Road, Nashik Road Nashik Maharashtra 422101 / IN | 02 /
KATKURWAR, Ashok B-10 Ishwar Paradise Apartment Ashoka marg Behind Fem Cinema Nashik road Nashik Maharashtra 422011 / IN | 03 /
GUPTA, Yashwant Flat No. 2 Antriksh Apartment Tagor Nagar Front of Ambedkar Nagar, Nashik Road Nashik Maharashtra 422006 / IN | 04 /
ANKAM, Rajesh Flat No. 204 E Wing Dream Nest DGP Nagar, Nashik Road Nashik Maharashtra 422101 / IN | 05 /
DHATRAK, Chandrakant S. No. 11/1-4 Plot No.9 Sadguru Krupa Bangloo Near Charandas Market, Jail Road, Nashik Road Nashik Maharashtra 422101 / IN | [2016/29] | Representative(s) | HGF HGF Limited 1 City Walk Leeds LS11 9DX / GB | [N/P] |
| Former [2021/26] | HGF 1 City Walk Leeds LS11 9DX / GB | ||
| Former [2016/29] | HGF Limited 1 City Walk Leeds LS11 9DX / GB | Application number, filing date | 14781946.0 | 04.09.2014 | [2016/29] | WO2014IB64251 | Priority number, date | IN2013MUM2975 | 13.09.2013 Original published format: IN 2975MU2013 | [2017/16] |
| Former [2016/29] | INMM29752013 | 13.09.2013 | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2015036902 | Date: | 19.03.2015 | Language: | EN | [2015/11] | Type: | A1 Application with search report | No.: | EP3043773 | Date: | 20.07.2016 | Language: | EN | The application published by WIPO in one of the EPO official languages on 19.03.2015 takes the place of the publication of the European patent application. | [2016/29] | Type: | B1 Patent specification | No.: | EP3043773 | Date: | 30.06.2021 | Language: | EN | [2021/26] | Search report(s) | International search report - published on: | EP | 19.03.2015 | Classification | IPC: | A61K9/10, A61K31/58, A61K31/335 | [2020/51] | CPC: |
A61K9/10 (EP,RU,US);
A61K31/573 (RU);
A61K47/38 (RU,US);
A61K31/335 (EP,US);
A61K31/55 (RU);
A61K31/58 (EP,US);
A61K47/02 (RU,US);
A61K47/26 (US);
A61K47/36 (RU,US);
A61K9/0043 (EP,RU,US);
A61P11/02 (EP,RU);
A61P27/14 (EP);
| C-Set: |
A61K31/335, A61K2300/00 (US,EP);
A61K31/58, A61K2300/00 (EP,US) |
| Former IPC [2016/29] | A61K9/00, A61K9/10, A61K31/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/29] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | STABILE PHARMAZEUTISCHE ZUSAMMENSETZUNG IN FESTER DOSIERUNG MIT MOMETASON UND OLOPATADIN | [2016/29] | English: | STABLE FIXED DOSE PHARMACEUTICAL COMPOSITION COMPRISING MOMETASONE AND OLOPATADINE FOR NASAL ADMINISTRATION | [2020/49] | French: | COMPOSITION PHARMACEUTIQUE STABLE À DOSE FIXE COMPRENANT DE LA MOMÉTASONE ET DE L'OLOPATADINE | [2020/52] |
| Former [2016/29] | STABLE FIXED DOSE PHARMACEUTICAL COMPOSITION COMPRISING MOMETASONE AND OLOPATADINE | ||
| Former [2016/29] | COMPOSITION PHARMACEUTIQUE STABLE À DOSE FIXE COMPRENANT DE LA MOMÉTASONE ET DE L'AZÉLASTINE | Entry into regional phase | 26.03.2015 | National basic fee paid | 26.03.2015 | Designation fee(s) paid | 26.03.2015 | Examination fee paid | Examination procedure | 26.03.2015 | Amendment by applicant (claims and/or description) | 26.03.2015 | Examination requested [2016/29] | 15.03.2018 | Despatch of a communication from the examining division (Time limit: M04) | 23.07.2018 | Reply to a communication from the examining division | 18.02.2020 | Despatch of a communication from the examining division (Time limit: M04) | 12.05.2020 | Reply to a communication from the examining division | 12.10.2020 | Despatch of a communication from the examining division (Time limit: M02) | 21.10.2020 | Reply to a communication from the examining division | 09.12.2020 | Communication of intention to grant the patent | 31.03.2021 | Fee for grant paid | 31.03.2021 | Fee for publishing/printing paid | 31.03.2021 | Receipt of the translation of the claim(s) | Divisional application(s) | EP20163589.3 / EP3718533 | Opposition(s) | Opponent(s) | 01
29.03.2022
31.03.2022
ADMISSIBLE Ter Meer Steinmeister & Partner Patentanwälte mbB Nymphenburger Strasse 4 80335 München / DE Opponent's representative Ter Meer Steinmeister & Partner, et al, et al Patentanwälte mbB Nymphenburger Straße 4 80335 München / DE | [2022/18] | 13.04.2022 | Invitation to proprietor to file observations on the notice of opposition | 22.08.2022 | Reply of patent proprietor to notice(s) of opposition | 09.11.2023 | Date of oral proceedings | 07.02.2024 | Despatch of interlocutory decision in opposition | 07.02.2024 | Despatch of minutes of oral proceedings | Appeal following opposition | 05.04.2024 | Appeal received No. T0492/24 | 05.04.2024 | Payment of appeal fee | 07.06.2024 | Statement of grounds filed | Fees paid | Renewal fee | 08.09.2016 | Renewal fee patent year 03 | 11.09.2017 | Renewal fee patent year 04 | 11.09.2018 | Renewal fee patent year 05 | 11.09.2019 | Renewal fee patent year 06 | 11.09.2020 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Licence(s) | ID: | 10 00/not-exclusive | For: | AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR | Licencee: | A. Menarini Farmaceutica Internazionale S.r.l. Via dei Sette Santi 1 50131 Florence / IT | Date: | 24.03.2021 | [2021/25] | Lapses during opposition Tooltip | deleted | [2024/08] |
| Former [2024/01] | SM | 15.06.2023 | |
| Former [2023/50] | AL | 30.06.2021 | |
| SM | 15.06.2023 | ||
| Former [2023/33] | SM | 15.06.2023 | |
| Former [2022/46] | deleted | ||
| Former [2022/26] | AL | 30.06.2021 | Cited in | International search | [IY]WO0126658 (SCHERING CORP [US]); | [YD]WO2011141929 (CADILA HEALTHCARE LTD [IN], et al); | [IY]WO2012094283 (ISTA PHARMACEUTICALS INC [US], et al); | [XDPYI]WO2014092346 (HANMI PHARM IND CO LTD [KR]) | Examination | US2004097474 | US2007099883 | WO2009003199 | US7977376 | by applicant | US4871865 | US4923892 | US6127353 | WO2006057769 | WO2010025236 | US7977376 | WO2011141929 | US8399508 | WO2014092346 | Opposition | WO0126658 | WO03105856 | US2004097474 | US2007099883 | WO2008047149 | WO2009003199 | US7977376 | WO2011141929 | WO2012094283 | WO2012093171 | US2013252929 | WO2014092346 |